✦ LIBER ✦

Phase II trial of topotecan and paclitaxel (TP) with G-CSF support alternating with etoposide and cisplatin (EC) in previously untreated extensive stage small cell lung cancer (ED-SCLC): A North Central Cancer Treatment Group study

✍ Scribed by Jett, J.R; Hatfield, A; Bauman, M; Hillman, S; Soori, G; Veeder, M; Morton, R

Book ID: 118569713
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 131 KB
Volume: 29
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)80168-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alternating chemotherapy with etoposide

Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma : A Phase II trial of the North Central Cancer Treatment Group

✍ James R. Jett; Alan K. Hatfield; Shauna Hillman; Michael D. Bauman; James A. Mai 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 3 views

## Abstract ## BACKGROUND The objective of this study was to test the response rate and toxicity of alternating chemotherapy in previously untreated patients with extensive‐stage small cell lung carcinoma (SCLC). ## METHODS Patients with histologically proven, extensive‐stage SCLC, with a perfor

A phase II study of cisplatin, etoposide

A phase II study of cisplatin, etoposide, and paclitaxel (PET) with G-CSF in untreated patients with extensive small cell lung cancer: A Southwest Oncology Group trial

✍ Kelly, K; Bunn, P.A; Lovato, L; Crowley, J; Livingston, R.B; Gandara, D.R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

A phase II trial of cisplatin and irinot

A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer

✍ Masahiro Tabata; Katsuyuki Kiura; Niro Okimoto; Yoshihiko Segawa; Tetsu Shinkai; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 262 KB

A weekly regimen of cisplatin, paclitaxe

A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study

✍ Frasci, G; Nicolella, G; Comella, P; Carreca, I; DeCataldis, G; Muci, D; Brunett 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 71 KB

O-277 CALGB 9732: Final report of a rand

O-277 CALGB 9732: Final report of a randomized phase III intergroup trial of etoposide(VP-16) and cisplatin (DDP) with or without paclitaxel(TAX) and G-CSF in patients with extensive stage small cell lung cancer(ED-SCLC)

✍ Niell, Harvey B.; Herndon, J.E.; Miller, A.A.; Watson, D.M.; Sandler, A.; Kelly, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 175 KB